{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:35:44Z","timestamp":1790087744511,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mrijournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.mri.2015.10.031","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T01:31:50Z","timestamp":1446600710000},"page":"353-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intramyocellular lipid content in subjects with impaired fasting glucose after telmisartan treatment, a randomised cross-over trial"],"prefix":"10.1016","volume":"34","author":[{"given":"Simona","family":"Kratochv\u00edlov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton\u00edn","family":"\u0160koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Wohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"\u0160vehl\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Dezortov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4704-6164","authenticated-orcid":false,"given":"Milan","family":"H\u00e1jek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezie","family":"Pelik\u00e1nov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mri.2015.10.031_bb0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mrm.1910290203","article-title":"Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue","volume":"29","author":"Schick","year":"1993","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mrm.1910370403","article-title":"In vivo determination of intramyocellular lipids in human muscle by means of localized 1H-MR spectroscopy","volume":"37","author":"Boesch","year":"1997","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0015","doi-asserted-by":"crossref","first-page":"E977","DOI":"10.1152\/ajpendo.1999.276.5.E977","article-title":"Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo","volume":"276","author":"Szcepaniak","year":"1999","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0020","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1152\/japplphysiol.01174.2001","article-title":"Content of intramyocellular lipids derived by electron microscopy, biochemical assays, and (1)H-MR spectroscopy","volume":"92","author":"Howald","year":"2002","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.mri.2015.10.031_bb0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diabetes.48.5.1113","article-title":"Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects","volume":"48","author":"Jacob","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.mri.2015.10.031_bb0030","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2337\/diabetes.48.8.1600","article-title":"Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents","volume":"48","author":"Perseghin","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.mri.2015.10.031_bb0035","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2337\/diabetes.50.10.2337","article-title":"Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle","volume":"50","author":"Virkam\u00e4ki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.mri.2015.10.031_bb0040","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1210\/jcem.86.12.8075","article-title":"Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes","volume":"86","author":"Goodpaster","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0045","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mri.2015.10.031_bb0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring with type 2 diabetes","volume":"350","author":"Petersen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0055","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2165\/00003495-200464220-00004","article-title":"Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system","volume":"64","author":"Scheen","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.mri.2015.10.031_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3132\/dvdr.2008.011","article-title":"Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus","volume":"5","author":"McGuire","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.mri.2015.10.031_bb0065","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.amjmed.2006.01.010","article-title":"The obese patient with diabetes mellitus: from research targets to treatment options","volume":"119","author":"Sharma","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0070","doi-asserted-by":"crossref","first-page":"549627","DOI":"10.1155\/2013\/549627","article-title":"Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases","volume":"2013","author":"Monsalve","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.mri.2015.10.031_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1530\/EJE-10-0436","article-title":"Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose","volume":"163","author":"Wohl","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.mri.2015.10.031_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2710.2011.01295.x","article-title":"Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes","volume":"37","author":"Suksomboon","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.mri.2015.10.031_bb0085","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mri.2015.10.031_bb0090","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mri.2015.10.031_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0026-0495(88)90110-2","article-title":"The theoretical bases of indirect calorimetry: a review","volume":"37","author":"Ferrannini","year":"1988","journal-title":"Metabolism"},{"key":"10.1016\/j.mri.2015.10.031_bb0100","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0105","first-page":"1077","article-title":"Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group","volume":"45","author":"International Federation of Clinical Chemistry and Laboratory Medicine","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0110","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/diab.37.9.1212","article-title":"Effect of hyperinsulinemia on urea pool size and substrate oxidation rates","volume":"37","author":"Tappy","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.mri.2015.10.031_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/08037051.2013.791411","article-title":"Metabolic effects of telmisartan in subjects with abdominal obesity: a prospective randomized controlled trial","volume":"23","author":"Chetty","year":"2014","journal-title":"Blood Press"},{"key":"10.1016\/j.mri.2015.10.031_bb0120","doi-asserted-by":"crossref","first-page":"983814","DOI":"10.1155\/2012\/983814","article-title":"Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions","volume":"2012","author":"Snel","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.mri.2015.10.031_bb0125","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.metabol.2007.06.005","article-title":"Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus","volume":"56","author":"Teranishi","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.mri.2015.10.031_bb0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1463-1326.2007.00801.x","article-title":"Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects","volume":"10","author":"Tamura","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0135","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/dia.2013.0013","article-title":"Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant \u03b1-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus","volume":"15","author":"Huang","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.mri.2015.10.031_bb0140","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/HJH.0b013e3282f9b58a","article-title":"Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway","volume":"26","author":"Sugimoto","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.mri.2015.10.031_bb0145","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2337\/db07-1828","article-title":"Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content","volume":"57","author":"Ravikumar","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.mri.2015.10.031_bb0150","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/jc.2009-0911","article-title":"Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus","volume":"95","author":"Bajaj","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0155","doi-asserted-by":"crossref","first-page":"E930","DOI":"10.1152\/ajpendo.00522.2004","article-title":"Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue","volume":"288","author":"Rasouli","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diabetes.51.3.797","article-title":"The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes","volume":"51","author":"Mayerson","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mri.2015.10.031_bb0165","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1210\/jc.2008-0267","article-title":"The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function","volume":"93","author":"Schrauwen-Hinderling","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/hr.2012.199","article-title":"Telmisartan modulates mitochondrial function in vascular smooth muscle cells","volume":"36","author":"Takeuchi","year":"2013","journal-title":"Hypertens Res"},{"key":"10.1016\/j.mri.2015.10.031_bb0175","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1291\/hypres.30.1205","article-title":"Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients","volume":"30","author":"Chujo","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.mri.2015.10.031_bb0180","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/HJH.0b013e3280287a83","article-title":"Effects of telmisartan on fat distribution in individuals with the metabolic syndrome","volume":"25","author":"Shimabukuro","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.mri.2015.10.031_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1479164112444640","article-title":"The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO)","volume":"10","author":"Murakami","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.mri.2015.10.031_bb0190","first-page":"1017","article-title":"Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity","volume":"32","author":"Huang","year":"2011","journal-title":"Saudi Med J"},{"key":"10.1016\/j.mri.2015.10.031_bb0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1464-5491.2009.02868.x","article-title":"Rosiglitazone decreases intra- to extramyocellular fat ratio in obese non-diabetic adults with metabolic syndrome","volume":"27","author":"Godoy-Matos","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0200","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0026-0495(00)91377-5","article-title":"Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides","volume":"49","author":"Manco","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.mri.2015.10.031_bb0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM199301283280404","article-title":"The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids","volume":"328","author":"Borkman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mri.2015.10.031_bb0210","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI118350","article-title":"Skeletal muscle membrane lipid composition is related to adiposity and insulin action","volume":"96","author":"Pan","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mri.2015.10.031_bb0215","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(03)14364-4","article-title":"Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning","volume":"362","author":"Weiss","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mri.2015.10.031_bb0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ajcn\/87.2.295","article-title":"Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals","volume":"87","author":"Koska","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mri.2015.10.031_bb0225","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1210\/jc.2007-0325","article-title":"Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation","volume":"92","author":"Perseghin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.beem.2013.08.003","article-title":"Adiponectin action in skeletal muscle","volume":"28","author":"Liu","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.mri.2015.10.031_bb0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00125-005-1686-6","article-title":"Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients","volume":"48","author":"Lattuada","year":"2005","journal-title":"Diabetologia"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X15002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X15002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T03:17:16Z","timestamp":1567307836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X15002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0730725X15002684"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2015.10.031","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramyocellular lipid content in subjects with impaired fasting glucose after telmisartan treatment, a randomised cross-over trial","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mri.2015.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}